Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 26% ± 7% |
Insufficient scRNA-seq data for expression of PRRX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 854.76 | 242 / 245 | 87% | 13.78 | 436 / 502 |
breast | 95% | 714.24 | 438 / 459 | 90% | 22.12 | 1002 / 1118 |
esophagus | 71% | 288.79 | 1028 / 1445 | 87% | 30.12 | 159 / 183 |
skin | 100% | 1675.36 | 1809 / 1809 | 57% | 12.20 | 271 / 472 |
uterus | 65% | 304.18 | 111 / 170 | 85% | 37.26 | 391 / 459 |
bladder | 95% | 640.24 | 20 / 21 | 51% | 8.80 | 256 / 504 |
thymus | 96% | 591.64 | 625 / 653 | 46% | 4.97 | 279 / 605 |
lung | 56% | 222.46 | 324 / 578 | 72% | 18.05 | 832 / 1155 |
ovary | 12% | 37.97 | 21 / 180 | 95% | 62.13 | 408 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.39 | 1 / 1 |
blood vessel | 99% | 1836.07 | 1328 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 686.15 | 1158 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 35.81 | 43 / 45 |
pancreas | 2% | 3.34 | 6 / 328 | 87% | 23.11 | 154 / 178 |
stomach | 26% | 81.47 | 94 / 359 | 59% | 14.62 | 170 / 286 |
lymph node | 0% | 0 | 0 / 0 | 72% | 7.98 | 21 / 29 |
intestine | 25% | 67.70 | 241 / 966 | 47% | 10.08 | 250 / 527 |
adrenal gland | 32% | 74.75 | 82 / 258 | 20% | 5.35 | 46 / 230 |
heart | 45% | 204.12 | 391 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 4.38 | 32 / 80 |
kidney | 6% | 17.11 | 5 / 89 | 12% | 1.41 | 111 / 901 |
muscle | 8% | 22.56 | 65 / 803 | 0% | 0 | 0 / 0 |
brain | 1% | 2.67 | 21 / 2642 | 6% | 1.37 | 43 / 705 |
liver | 0% | 0 | 0 / 226 | 6% | 0.69 | 25 / 406 |
peripheral blood | 0% | 0.81 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | PRRX2 |
Protein name | Paired mesoderm homeobox protein 2 (Paired-related homeobox protein 2) (PRX-2) |
Synonyms | PMX2 PRX2 |
Description | FUNCTION: May play a role in the scarless healing of cutaneous wounds during the first two trimesters of development. . |
Accessions | ENST00000372469.6 Q99811 |